Looking Into Johnson & Johnson’s Recent Short Interest
Johnson & Johnson’s (NYSE:JNJ) short percent of float has risen 115.22% since its last report. The company recently reported that it has 25.73 million shares sold short, which is 0.99% of all regular shares that are available for trading. Based on its trading volume, it would take traders 1.94 days to cover their short positions […]
Janet Yellen Joins The Shroom Trend, Sort Of, During Her Official Visit To China
In a recent interview with CNN, U.S. Treasury Secretary Janet Yellen casually recognized that she tried magic mushrooms at a dinner during her July official visit to China. Although “delicious,” the mushrooms didn’t make her trip. Yellen added that she was only informed that the meal was made of the psychoactive native Lanmaoa asiatica shrooms after … […]
What 7% Mortgage Rates Mean for Home Buyers
Buyers should focus on what they can control rather than try to predict mortgage rates.Read More
How a Small Group of Firms Changed the Math for Insuring Against Natural Disasters
Climate change, inflation and global instability have thrust companies that sell insurance to insurers into the spotlight.Read More
New Tax-Credit Market Aims to Funnel Billions to Clean Energy
First deal in federal program helps fund $1.5 billion wind-energy transaction.Read More
So, You Want to Be a Tax Whistleblower
It takes a lot of time and determination, but the payoff from the IRS could be huge. Here’s how to do it.Read More
When Hackers Descended to Test A.I., They Found Flaws Aplenty
The hackers had the blessing of the White House and leading A.I. companies, which want to learn about vulnerabilities before those with nefarious intentions do.Read More
In Scathing Letter, New York State Criticizes Adams’s Migrant Response
The letter, responding to New York City’s list of demands for state help, said the city had already rebuffed some of the state’s offers and had been slow to help migrants.Read More
Vivos Therapeutics Reschedules Second Quarter 2023 Financial Results Conference Call
LITTLETON, Colo., Aug. 16, 2023 (GLOBE NEWSWIRE) — Vivos Therapeutics, Inc. (“Vivos” or the “Company”) (NASDAQ:VVOS), a medical technology company focused on developing and commercializing innovative diagnostic and treatment methods for patients suffering from a variety of health conditions, many of which are associated with breathing related sleep conditions arising from certain dentofacial abnormalities, today […]
Time to Take Up Take-Two
Grand Theft Auto’s publisher still might be a steal ahead of a major release cycle.Read More
